Viscogliosi Brothers Acquisition Corp

Viscogliosi Brothers Acquisition Corp (Nasdaq: VBOC), sponsored by Viscogliosi Brothers LLC, priced its initial public offering in 2021 with a stated focus on the healthcare sector, specifically targeting opportunities in orthopedic and musculoskeletal medical technology. The Viscogliosi family brings long-standing industry experience in orthopedic device development and commercialization, which shaped the SPAC's sector thesis from launch. On June 28, 2023, the company filed a DEFA14A with the SEC, a form used to deliver additional definitive proxy solicitation materials to shareholders in connection with a pending vote, reflecting active shareholder engagement during its post-IPO timeline. Sign up at SpacDesk for full filing history, status tracking, and analytics on VBOC and the broader SPAC universe.